BDBM478581 1-{4-[(1R or 1S)-1-{2-[(6-{1-[(1-chlorocyclopropyl)methyl]-1H-pyrazol-4-yl}-1H-benzimidazol-2-yl)amino]pyridin-4-yl}ethyl]piperazin-1-yl}-3,3,3-trifluoropropan-1-one::US10894784, Example 69.02

SMILES CC(N1CCN(CC1)C(=O)CC(F)(F)F)c1ccnc(Nc2nc3ccc(cc3[nH]2)-c2cnn(CC3(Cl)CC3)c2)c1

InChI Key InChIKey=WIPYYGVJMFILKH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 478581   

TargetSerine/threonine-protein kinase TBK1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM478581(US10894784, Example 69.02 | 1-{4-[(1R or 1S)-1-{2-...)
Affinity DataIC50: 0.640nMAssay Description:Recombinant full-length N-terminally His-tagged human TBK1, expressed in insect cells and purified by Ni-NTA affinity chromatography, was purchased f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent